These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 1983397)

  • 21. [Neuroleptics and dopamine. How the antipsychotic breakthrough resulted in improved knowledge about the biology of schizophrenia].
    Fog R
    Ugeskr Laeger; 2000 Jan; 162(1):68-9. PubMed ID: 10658506
    [No Abstract]   [Full Text] [Related]  

  • 22. Central dopaminergic mechanisms in schizophrenia.
    Owen F; Crow TJ; Poulter M
    Acta Psychiatr Belg; 1987; 87(5):552-65. PubMed ID: 2897760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia].
    Guise S; Soubrouillard C; Blin O
    Encephale; 1997 Apr; 23 Spec No 2():10-6. PubMed ID: 9273300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in cerebral dopamine metabolism and receptors during one-year neuroleptic administration and subsequent withdrawal: relevance to brain biochemistry in schizophrenia.
    Clow A; Jenner P; Theodorou A; Marsden CD
    Adv Biochem Psychopharmacol; 1980; 24():53-5. PubMed ID: 6105799
    [No Abstract]   [Full Text] [Related]  

  • 25. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine receptors, antipsychotic action and schizophrenia.
    Reynolds GP
    J Psychopharmacol; 1999; 13(2):202-3. PubMed ID: 10475731
    [No Abstract]   [Full Text] [Related]  

  • 27. Receptor mechanisms in the treatment of schizophrenia.
    Reynolds GP
    J Psychopharmacol; 2004 Sep; 18(3):340-5. PubMed ID: 15358977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study shows newer schizophrenia treatments no more effective than old.
    Frantz S
    Nat Rev Drug Discov; 2005 Nov; 4(11):872-3. PubMed ID: 16299914
    [No Abstract]   [Full Text] [Related]  

  • 29. In vivo neuropharmacology of schizophrenia.
    Bigliani V; Pilowsky LS
    Br J Psychiatry Suppl; 1999; (38):23-33. PubMed ID: 10884897
    [No Abstract]   [Full Text] [Related]  

  • 30. [New pharmacological approaches to the treatment of schizophrenia].
    Uzbay IT
    Turk Psikiyatri Derg; 2009; 20(2):175-82. PubMed ID: 19504368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropharmacology of zotepine, an antimanic drug: a potent blocker of D2 and 5-HT2 receptors of human brain.
    Kanba S; Yagi G; Oguchi E; Nakaki T; Kato R; Richelson E
    Jpn J Psychiatry Neurol; 1991 Mar; 45(1):133-4. PubMed ID: 1684393
    [No Abstract]   [Full Text] [Related]  

  • 32. [Physiopathology of schizophrenia. Some biologic aspects].
    Tissot R
    Schweiz Arch Neurol Neurochir Psychiatr; 1984; 135(1):29-40. PubMed ID: 6148787
    [No Abstract]   [Full Text] [Related]  

  • 33. Serotonin involvement in the metamorphosis of the hydroid Eudendrium racemosum.
    Zega G; Pennati R; Fanzago A; De Bernardi F
    Int J Dev Biol; 2007; 51(4):307-13. PubMed ID: 17554682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine and schizophrenia.
    Crow TJ; Johnstone EC; Longden A; Owen F
    Adv Biochem Psychopharmacol; 1978; 19():301-9. PubMed ID: 29450
    [No Abstract]   [Full Text] [Related]  

  • 35. [Biochemistry of schizophrenia and mechanism of action of neuroleptics].
    Loo H; Cuche H; Sechter D
    Sem Hop; 1982 Dec; 58(44):2565-72. PubMed ID: 6130604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action.
    Reynolds GP; Rossor MN; Iversen LL
    J Neural Transm Suppl; 1983; 18():273-7. PubMed ID: 6135746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Psychopharmacologic approaches to schizophrenic psychoses].
    Giacardy-Paty M; Soubrouillard C; Blin O
    Encephale; 1995 Jun; 21 Spec No 3():3-8. PubMed ID: 7628339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards more effective antipsychotic treatment.
    Kane JM; Freeman HL
    Br J Psychiatry Suppl; 1994 Nov; (25):22-31. PubMed ID: 7865194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does dopamine have a role in schizophrenia?
    Carlsson A
    Biol Psychiatry; 1978 Feb; 13(1):3-21. PubMed ID: 341997
    [No Abstract]   [Full Text] [Related]  

  • 40. [Influence of the selective ligands of dopamine and 5-hydroxytryptamine receptors on the tolerance to global cerebral ischemia].
    Kulinskiĭ VI; Gavrilov SS
    Eksp Klin Farmakol; 2006; 69(6):20-3. PubMed ID: 17209458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.